Millennium Management

Metagenomi, Inc. is a genetic medicines company based in Emeryville, California, focused on developing innovative gene editing systems for the treatment of genetic diseases. Since its incorporation in 2016, the company has utilized a proprietary metagenomics-derived genome editing toolbox that enables the creation of curative therapeutics. This toolbox encompasses a range of advanced technologies, including programmable nucleases, base editors, and various RNA and DNA-mediated integration systems, such as prime editing systems and CRISPR-associated transposases (CASTs). Metagenomi aims to address the challenges posed by diverse mutations that have traditionally been difficult to target with existing genome engineering approaches.

HFCL, The Company specializes in manufacturing of telecommunication equipment.

Sarcos is a wearable and teleoperated industrial robotics company that augments humans to enhance productivity and safety. Sarcos Robotics augments human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Leveraging more than 25 years of research and development, Sarcos’ mobile robotic systems, including the Guardian® S, Guardian® GT, and Guardian® XO®, are revolutionizing the future of work wherever physically demanding work is done. Formerly the robotics division of a major defense contractor, Sarcos is based in Salt Lake City, Utah, powered by an innovative team of entrepreneurs and engineers, and backed by Caterpillar, GE Ventures, Microsoft, and Schlumberger.

Kurly Inc. operates an online premium grocery service based in Seoul, South Korea, specializing in the retail of food products. The company offers a wide range of items including fresh vegetables, fruits, cereals, fish, meat, eggs, seasonings, baked goods, and processed foods, all sourced directly from producers. Founded in 2014, Kurly enables customers to order high-quality ingredients through its platform and ensures next-day delivery, emphasizing freshness and quality. The service caters to consumers seeking premium food options, including fresh desserts and various condiments.

Kurly Inc. operates an online premium grocery service based in Seoul, South Korea, specializing in the retail of food products. The company offers a wide range of items including fresh vegetables, fruits, cereals, fish, meat, eggs, seasonings, baked goods, and processed foods, all sourced directly from producers. Founded in 2014, Kurly enables customers to order high-quality ingredients through its platform and ensures next-day delivery, emphasizing freshness and quality. The service caters to consumers seeking premium food options, including fresh desserts and various condiments.

Payoneer Inc. operates a cross-border payments platform designed to facilitate global commerce by connecting businesses, professionals, countries, and currencies. Founded in 2005 and headquartered in New York, the company offers products such as the Global Payment Service, which provides users with local receiving accounts in the United States, European Union, and Japan, allowing for direct local bank transfers. Additionally, Payoneer enables users to receive payments from various integrated partners, including those in freelance, e-commerce, and online advertising sectors. The company also provides mass payout services that assist Indian companies in transferring funds internationally. Serving millions of users across over 200 countries, Payoneer is a trusted partner for numerous prominent corporations, making cross-border payments as straightforward as local transactions.

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Caris Life Sciences is a biotechnology company based in Irving, Texas, specializing in precision medicine and cancer treatment. Founded in 1996, the company develops and commercializes advanced diagnostic technologies, including anatomic pathology and molecular profiling, to enhance the understanding of cancer biology. Its services encompass comprehensive molecular analyses of patient samples, integrating genomic, transcriptomic, and proteomic profiling through the Caris Molecular Intelligence platform. This platform aids physicians and cancer patients in making informed and personalized treatment decisions by revealing the molecular blueprint of complex diseases. Caris Life Sciences serves a global customer base through distributors in regions including the United States, Europe, and Australia, and maintains a strategic collaboration with Debiopharm International SA. The company is committed to improving patient outcomes through innovative scientific advancements and a focus on quality care.

Deep Instinct Ltd. is a cybersecurity company founded in 2014, headquartered in Tel Aviv, Israel, with an additional office in New York. The company specializes in providing advanced cybersecurity solutions that utilize deep learning technology to detect and prevent zero-day threats and advanced persistent threat attacks. Its on-device solution offers real-time protection for various endpoints and mobile devices, regardless of their connection to the network or the Internet. By leveraging deep learning's predictive capabilities, Deep Instinct aims to deliver high accuracy in safeguarding enterprises against unknown and evasive cyber-attacks. This innovative approach allows for the identification and blocking of potential threats before they can inflict damage, enhancing the overall security posture of organizations.

Starling Bank Limited is a digital-only bank headquartered in London, United Kingdom, founded in 2014 by Anne Boden. Originally known as Starling FS Limited, the institution rebranded in July 2016. Starling Bank specializes in providing personal and business banking services through its mobile banking application, which allows users to manage their finances efficiently. The platform offers features such as real-time spending intelligence, the ability to send money to friends, and tools for collaborative savings. Customers can conduct transactions in a paperless and branchless manner, ensuring a streamlined and personalized banking experience.

WeDoctor Holdings (Zhejiang) Co., Ltd. is a prominent medical technology platform based in Hangzhou, China, founded in 2010. The company specializes in developing medical cloud and artificial intelligence solutions that cater to governments, hospitals, and healthcare institutions. WeDoctor provides a comprehensive cloud platform that facilitates both online and offline medical services, including general practice, specialty consultations, and appointment scheduling. Additionally, it operates a managed health services platform known as WeDoctor HMO, aimed at enhancing medical care accessibility and efficiency. By leveraging technology, WeDoctor strives to improve health management for users, positioning itself as a significant player in the health maintenance organization sector. Through its innovative approach, the company aims to serve as a crucial health resource for millions of families.

SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Caris Life Sciences is a biotechnology company based in Irving, Texas, specializing in precision medicine and cancer treatment. Founded in 1996, the company develops and commercializes advanced diagnostic technologies, including anatomic pathology and molecular profiling, to enhance the understanding of cancer biology. Its services encompass comprehensive molecular analyses of patient samples, integrating genomic, transcriptomic, and proteomic profiling through the Caris Molecular Intelligence platform. This platform aids physicians and cancer patients in making informed and personalized treatment decisions by revealing the molecular blueprint of complex diseases. Caris Life Sciences serves a global customer base through distributors in regions including the United States, Europe, and Australia, and maintains a strategic collaboration with Debiopharm International SA. The company is committed to improving patient outcomes through innovative scientific advancements and a focus on quality care.